Paul Bisaro previously served as executive chairman of Allergan, and president, CEO and chairman of the board of Actavis.
Specialty Pharmacy News
Patients taking Genentech drug can live an average of 2.47 years longer than those with best supportive care treatment, research concludes.
Mike Agostino will return as president to Amber Pharmacy as Aaron Wiese leaves the position to become Hy-Vee VP strategy/innovation.
DSN examines chain pharmacy, including in-depth coverage of the specialty market, in this multi-page report.
Specialty and biotech medicines aimed at treating cancer, multiple sclerosis and rare diseases will dominate much of drug development in 2017 and beyond, one of the nation’s top specialty pharmacy providers concluded.
Among the 22 novel new drugs approved by the Food and Drug Administration in 2016, about half were considered specialty drugs.
Epic will help integrate and improve clinical processes for CVS Specialty, including Accordant, which provides care management program services for patients with rare, chronic diseases.
Memphis-based company is seeing continued improvement in its retail and specialty pharmacy divisions.
The pharmacy staff at cancer-specialized specialty pharmacies have completed a cancer-focused curriculum of advanced education courses, focused on colorectal, lung, prostate and breast cancer, as well as various blood cancers.
The Pharmaceutical Research and Manufacturers of America has announced leadership changes to some of its advocacy efforts as longtime SVP advocacy Jeff Bond is set to retire.